
Discover Viatris
Viatris Reports Second Quarter 2025 Results and Reiterates 2025 Financial Guidance

Discover Viatris
Viatris Announces Appointment of David Simmons to the Company's Board of Directors

Discover Viatris
Viatris Announces Five Data Presentations on Novel Fast-Acting Meloxicam (MR-107A-02) at PAINWeek 2025 Conference

Discover Viatris